MARKET

ONCO

ONCO

Onconetix
NASDAQ
1.030
-0.010
-0.96%
After Hours: 1.070 +0.04 +3.88% 18:02 06/05 EDT
OPEN
0.9700
PREV CLOSE
1.040
HIGH
1.050
LOW
0.9201
VOLUME
522.80K
TURNOVER
--
52 WEEK HIGH
382.50
52 WEEK LOW
0.9110
MARKET CAP
1.18M
P/E (TTM)
-0.0024
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ONCO last week (0525-0529)?
Weekly Report · 4d ago
Realbotix swings to Q2 FY26 profit of USD 442,375; revenue falls to USD 225,000
PUBT · 05/29 11:30
Weekly Report: what happened at ONCO last week (0518-0522)?
Weekly Report · 05/25 10:21
Onconetix Inc trading halted, news pending
TipRanks · 05/20 23:50
Onconetix Implements 1-for-10 Reverse Stock Split For Nasdaq Compliance; Stock Down
NASDAQ · 05/20 07:49
Onconetix Sets 1-for-10 Reverse Stock Split Effective
TipRanks · 05/19 20:52
BUZZ-U.S. STOCKS ON THE MOVE- Hims & Hers Health, Driven Brands, Onto Innovation
Reuters · 05/19 17:42
Gold Falls 1%; Amer Sports Earnings Top Views
Benzinga · 05/19 16:29
More
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Webull offers Onconetix Inc stock information, including NASDAQ: ONCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCO stock methods without spending real money on the virtual paper trading platform.